Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.
Saved in:
| Title: | Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. |
|---|---|
| Authors: | Márquez-Rodas I; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain. ivanpantic@hotmail.com., Longo F; Medical Oncology Department, Hospital Ramón y Cajal, IRYCIS and CIBERONC, Madrid28034, Spain., Rodriguez-Ruiz ME; CIMA and Clínica Universidad de Navarra and CIBERONC, Pamplona 31008, Spain., Calles A; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Ponce S; Medical Oncology Department, Hospital 12 de Octubre, Madrid 28041, Spain., Jove M; Medical Oncology Department, Institut Català d'Oncologia, Barcelona 08908, Spain., Rubio-Viqueira B; Medical Oncology Department, Hospital Universitario Quirónsalud, Madrid 28223, Spain., Perez-Gracia JL; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona 31008, Spain., Gómez-Rueda A; Medical Oncology Department, Hospital Ramón y Cajal, IRYCIS and CIBERONC, Madrid28034, Spain., López-Tarruella S; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Ponz-Sarvise M; CIMA and Clínica Universidad de Navarra and CIBERONC, Pamplona 31008, Spain., Álvarez R; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Soria-Rivas A; Medical Oncology Department, Hospital Ramón y Cajal, IRYCIS and CIBERONC, Madrid28034, Spain., de Miguel E; Radiology Department, Hospital General Universitario Gregorio Marañón, Madrid 28007, Spain., Ramos-Medina R; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Castañon E; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona 31008, Spain., Gajate P; Medical Oncology Department, Hospital Ramón y Cajal, IRYCIS and CIBERONC, Madrid28034, Spain., Sempere-Ortega C; Radiology Department, Hospital Ramón y Cajal, Madrid 28034, Spain., Jiménez-Aguilar E; Medical Oncology Department, Hospital 12 de Octubre, Madrid 28041, Spain., Aznar MA; CIMA and Clínica Universidad de Navarra and CIBERONC, Pamplona 31008, Spain., Calvo A; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Lopez-Casas PP; Highlight Therapeutics (formerly known as Bioncotech Therapeutics), Valencia 46980, Spain., Martín-Algarra S; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona 31008, Spain., Martín M; Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC, Madrid 28007, Spain., Tersago D; Highlight Therapeutics (formerly known as Bioncotech Therapeutics), Valencia 46980, Spain., Quintero M; CIMA and Clínica Universidad de Navarra and CIBERONC, Pamplona 31008, Spain., Melero I; CIMA and Clínica Universidad de Navarra and CIBERONC, Pamplona 31008, Spain. |
| Source: | Science translational medicine [Sci Transl Med] 2020 Oct 14; Vol. 12 (565). |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.abb0391 |
